Canadian Activase for Stroke Effectiveness Study "CASES"

Completed

Phase 4 Results

Summary of Purpose

To prospectively evaluate the use of intravenous rt-PA in Canada. Thrombolytic therapy for acute stroke in Canada was conditionally approved in 1999; this study was a mandated by the federal government as a condition for full approval.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Canadian Stroke Consortium, Canadian Stroke Network, and Hoffman-La Roche Canada Ltd.

Trial Design

Open label, multi-center post-marketing study.

Contacts

  • CASES Study Group Calgary, AB, Canada

    Michael.hill@crha-health.ab.ca